Are there any side effects of taking Eltrombopag for a long time?

Eltrombopag (eg, eltrombopag ethanolamine tablets) is a drug used to treat chronic immune (idiopathic) thrombocytopenic purpura (ITP) by promoting platelet production to increase platelet counts. Questions about whether long-term use of eltrombopag will have side effects

Eltrombopag may increase blood clotting, increasing the risk of thrombosis. Platelet count and other related indicators should be closely monitored during long-term use to prevent serious complications such as microvascular embolism and organ infarction.

Eltrombopag may cause certain damage to the liver, manifested by abnormal liver function, such as increased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and bilirubin. Liver function should be monitored regularly during long-term use to detect and deal with potential hepatotoxicity in a timely manner.

Eltrombopag may stimulate the smooth muscles of the gastrointestinal tract and cause gastrointestinal dysfunction, such as nausea, vomiting, loss of appetite and other symptoms. Some patients may experience gastrointestinal adverse symptoms such as stomach pain and indigestion.

Long-term use of eltrombopag may cause neurological symptoms such as headache, dizziness, drowsiness, or weakness. These symptoms may be related to the drug's effects on the central nervous system.

Some patients may have allergic reactions to eltrombopag, manifesting as rash, urticaria, itching, difficulty breathing and other symptoms. Severe allergic reactions can be life-threatening and require immediate medical attention.

Long-term use of eltrombopag may also cause adverse reactions such as muscle pain, paresthesias, cataracts, menstrual disorders, hair loss, and influenza-like illness. The incidence and severity of these adverse reactions vary among individuals.

Eltrombopag should be used strictly in accordance with medical instructions, including dosage, usage and medication time. Patients should not adjust dosage or discontinue medication on their own. During the period of using eltrombopag, patients should regularly monitor blood routine, liver function and other related indicators to detect and deal with potential side effects in a timely manner. Patients should pay close attention to their physical reactions while taking Eltrombopag, and seek medical attention promptly if symptoms of discomfort occur. Especially when serious adverse reactions such as allergic reactions and signs of thromboembolism occur, the drug should be discontinued immediately and medical assistance should be sought.